Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/ACM) – Dr Rachel Bastiaenen

Dr Bastiaenen introduces the diagnosis, and treatment for arrhythmogenic cardiomyopathy.
Help us be there for everyone that needs us through a one-off donation or a regular gift – https://www.cardiomyopathy.org/donate
Chapters:
00:01:54 – What is arrhythmogenic right ventricular cardiomyopathy?
00:09:10 – Recognition of left-sided disease
00:10:49 – 2023 ESC Guidelines for Management of Cardiomyopathies
00:12:24 – Genetics
00:18:08 – Diagnosis
00:30:35 – Lifestyle and exercise
00:32:17 – Treatment options
00:34:56 – Risk stratification
00:36:47 – ICD
00:37:40 – Psychological support
00:39:40 – New developments and future directions
Audience questions
00:46:53 – What developments have taken place in ICDs?
00:48:25 – Do all ICDs pace and shock?
00:49:40 – What do the new classifications around ARVC mean?
00:52:00 – Is gene therapy available for ARVC?
00:52:55 – Will there be personalised treatment for ARVC?
00:54:30 – Is anyone using AI in treatment?
00:55:12 – What is the importance of inflammation in ARVC?

Dr Rachel Bastiaenen is a Consultant Cardiologist at Guy’s and St Thomas’ NHS Foundation Trust where she is the Clinical Director for Cardiovascular at Guy’s and St Thomas’. She is an Honorary Senior Lecturer at King’s College London. She studied at Peterhouse Cambridge and Imperial College London. She completed her cardiology training in the London Deanery and a Fellowship in Vancouver.
Her PhD was awarded from St George’s University of London and involved non-invasive risk stratification of patients with cardiomyopathy. She has presented her work at national and international conferences and has a series of publications in peer reviewed journals. Her PhD was awarded from St George’s University of London in 2014. She has ongoing research interests in arrhythmogenic right ventricular cardiomyopathy and Brugada syndrome.

Find out more at www.cardiomyopathy.org